Oragenics, Inc. (OGEN)
0.4109
+0.01
(+1.38%)
USD |
NYAM |
Oct 23, 16:00
0.4109
0.00 (0.00%)
After-Hours: 20:00
Oragenics EPS Diluted (Quarterly) : -0.571 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.571 |
| March 31, 2026 | -0.5118 |
| December 31, 2025 | -0.5354 |
| September 30, 2025 | -1.965 |
| June 30, 2025 | -3.105 |
| March 31, 2025 | -0.1217 |
| December 31, 2024 | -7.993 |
| September 30, 2024 | -0.3773 |
| June 30, 2024 | -0.509 |
| March 31, 2024 | -0.701 |
| December 31, 2023 | -4.138 |
| September 30, 2023 | -0.8543 |
| June 30, 2023 | -1.507 |
| March 31, 2023 | -1.405 |
| December 31, 2022 | -0.906 |
| September 30, 2022 | -1.989 |
| June 30, 2022 | -3330.65 |
| March 31, 2022 | -2.366 |
| December 31, 2021 | -1.182 |
| September 30, 2021 | -2.263 |
| June 30, 2021 | -1.976 |
| March 31, 2021 | -3.041 |
| December 31, 2020 | -2.983 |
| September 30, 2020 | -4.522 |
| June 30, 2020 | -14.17 |
| Date | Value |
|---|---|
| March 31, 2020 | -6.748 |
| December 31, 2019 | -4.679 |
| September 30, 2019 | -4.991 |
| June 30, 2019 | -6.253 |
| March 31, 2019 | -6.531 |
| December 31, 2018 | -5.617 |
| September 30, 2018 | -20.96 |
| June 30, 2018 | -22.70 |
| March 31, 2018 | -25.48 |
| December 31, 2017 | -17.78 |
| September 30, 2017 | -25.17 |
| June 30, 2017 | -14.87 |
| March 31, 2017 | -24.00 |
| December 31, 2016 | -30.00 |
| September 30, 2016 | -23.98 |
| June 30, 2016 | -26.45 |
| March 31, 2016 | -900.00 |
| December 31, 2015 | -1080.00 |
| September 30, 2015 | -30.00 |
| June 30, 2015 | -102.00 |
| March 31, 2015 | -24.00 |
| December 31, 2014 | -18.00 |
| September 30, 2014 | -18.00 |
| June 30, 2014 | -30.00 |
| March 31, 2014 | -30.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.529M |
| Total Expenses (Quarterly) | 2.529M |
| Enterprise Value | -2.036M |
| Earnings Yield | -871.9% |
| Normalized Earnings Yield | -871.94 |